PL1820509T3 - Preparat leczniczy FVIIa o bardzo wysokiej czystości i sposób jego otrzymywania - Google Patents

Preparat leczniczy FVIIa o bardzo wysokiej czystości i sposób jego otrzymywania

Info

Publication number
PL1820509T3
PL1820509T3 PL07380021T PL07380021T PL1820509T3 PL 1820509 T3 PL1820509 T3 PL 1820509T3 PL 07380021 T PL07380021 T PL 07380021T PL 07380021 T PL07380021 T PL 07380021T PL 1820509 T3 PL1820509 T3 PL 1820509T3
Authority
PL
Poland
Prior art keywords
therapeutic preparation
fvlla
high purity
obtaining same
preparation
Prior art date
Application number
PL07380021T
Other languages
English (en)
Inventor
Gamon Salvador Grancha
Debart Pere Ristol
Nieto Juan Ignacio Jorquera
Original Assignee
Grifols Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36676691&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1820509(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Grifols Sa filed Critical Grifols Sa
Publication of PL1820509T3 publication Critical patent/PL1820509T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PL07380021T 2006-02-17 2007-02-05 Preparat leczniczy FVIIa o bardzo wysokiej czystości i sposób jego otrzymywania PL1820509T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200600373A ES2257225B1 (es) 2006-02-17 2006-02-17 Preparacion terapeutica de fviia de muy alta pureza y metodo para su obtencion.
EP07380021A EP1820509B1 (en) 2006-02-17 2007-02-05 Therapeutic preparation of very high purity FVlla and method for obtaining same

Publications (1)

Publication Number Publication Date
PL1820509T3 true PL1820509T3 (pl) 2009-12-31

Family

ID=36676691

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07380021T PL1820509T3 (pl) 2006-02-17 2007-02-05 Preparat leczniczy FVIIa o bardzo wysokiej czystości i sposób jego otrzymywania

Country Status (8)

Country Link
US (1) US7531513B2 (pl)
EP (1) EP1820509B1 (pl)
JP (1) JP5196799B2 (pl)
AT (1) ATE435657T1 (pl)
DE (1) DE602007001467D1 (pl)
ES (2) ES2257225B1 (pl)
PL (1) PL1820509T3 (pl)
PT (1) PT1820509E (pl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102046653B (zh) * 2008-05-30 2015-02-18 诺沃-诺迪斯克保健股份有限公司 控制多肽修饰反应的方法
ES2578729T3 (es) * 2009-08-28 2016-07-29 Osaka Air Machine Service, Ltd. Agente terapéutico para enfermedades relacionadas con el hígado
AU2011343813B2 (en) 2010-12-15 2015-05-21 Takeda Pharmaceutical Company Limited Eluate collection using conductivity gradient
WO2017189919A2 (en) 2016-04-28 2017-11-02 Alkahest, Inc. Blood plasma and plasma fractions as therapy for tumor growth and progression
HUE056294T2 (hu) 2016-08-18 2022-02-28 Alkahest Inc Vérplazma frakciók korral összefüggõ kognitív rendellenesség kezelésére
UA127828C2 (uk) 2017-04-26 2024-01-17 Алкахест, Інк. Спосіб застосування фракції білків плазми крові для лікування когнітивних порушень
WO2020018343A1 (en) 2018-07-20 2020-01-23 Alkahest, Inc. Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasma products
CA3115308A1 (en) 2018-10-26 2020-04-30 Alkahest, Inc. Use of plasma and plasma fractions for improvement of pain, wound healing, and postoperative recovery
CA3151943A1 (en) 2019-11-04 2021-05-14 Viktoria Kheifets Blood plasma fractions for use in muscle regeneration
US11660316B2 (en) 2019-11-20 2023-05-30 Alkahest, Inc. Methods of inducing liver regeneration by administering a plasma protein fraction
AU2024244773A1 (en) 2023-03-29 2025-10-30 Grifols Worldwide Operations Limited COMPOSITIONS AND METHODS OF PREPARATION OF BLOOD PLASMA PRODUCTS WITH REDUCED LEVELS OF FceRIß AUTOANTIBODIES
WO2025230830A1 (en) 2024-04-29 2025-11-06 Alkahest, Inc. Compositions of blood plasma fractions and their use in treatment of spinal muscular atrophy (sma)

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4479938A (en) * 1981-06-25 1984-10-30 Baxter Travenol Laboratories, Inc. Therapeutic composition containing factor VIIa
US4470969A (en) * 1983-12-02 1984-09-11 Miles Laboratories, Inc. Process for producing a concentrate of coagulation factors VII and VIIa
FR2632524B1 (fr) * 1988-06-09 1992-03-13 Fondation Nale Transfusion San Procede de preparation d'une fraction concentree en facteur viia et son application a titre de medicament
FR2684999A1 (fr) * 1991-12-16 1993-06-18 Aquitaine Dev Transf Sanguine Procede de fabrication d'un concentre de facteur vii active de haute purete essentiellement depourvu des facteurs vitamine k dependants et des facteurs viiic et viiicag.
DE19531637A1 (de) * 1995-08-28 1997-03-06 Immuno Ag Pharmazeutische Zusammensetzung zur Behandlung von Blutgerinnungsstörugnen, Verfahren zur Herstellung derselben und deren Verwendung
US6310183B1 (en) * 1997-09-10 2001-10-30 Novo Nordisk A/S Coagulation factor VIIa composition
JP2000103800A (ja) * 1998-09-29 2000-04-11 Yoshitomi Pharmaceut Ind Ltd 免疫グロブリンａの精製方法
JP5090605B2 (ja) * 2000-05-03 2012-12-05 ノボ ノルディスク ヘルス ケア アクチェンゲゼルシャフト 凝固因子ｖｉｉの皮下投与
DE10211632A1 (de) * 2002-03-15 2003-10-09 Aventis Behring Gmbh Verfahren zur Abtrennung von Viren aus einer Proteinlösung durch Nanofiltration
CA2490342C (en) * 2002-06-21 2015-06-16 Novo Nordisk A/S Stabilised solid compositions of factor vii polypeptides
EP1713906A2 (en) * 2004-02-03 2006-10-25 Novo Nordisk Health Care AG Coagulation factor vii/viia variants lacking functional lipid membrane binding domain
US20070037966A1 (en) * 2004-05-04 2007-02-15 Novo Nordisk A/S Hydrophobic interaction chromatography purification of factor VII polypeptides
JP5112060B2 (ja) * 2004-06-29 2013-01-09 リライアンス ライフ サイエンシーズ プライベイト リミテッド ウイルス安全性生物学的流体の調製のための方法

Also Published As

Publication number Publication date
EP1820509B1 (en) 2009-07-08
DE602007001467D1 (de) 2009-08-20
ES2327013T3 (es) 2009-10-22
ATE435657T1 (de) 2009-07-15
ES2257225A1 (es) 2006-07-16
US7531513B2 (en) 2009-05-12
ES2257225B1 (es) 2007-03-16
PT1820509E (pt) 2009-09-02
EP1820509A1 (en) 2007-08-22
JP2007217415A (ja) 2007-08-30
US20070197440A1 (en) 2007-08-23
JP5196799B2 (ja) 2013-05-15

Similar Documents

Publication Publication Date Title
PT1820509E (pt) Preparação terapêutica de fviia de pureza muito elevada e método para obter a mesma
WO2004083361A3 (en) FVII OR FVIIa VARIANTS
EP2279244A4 (en) METHOD AND COMPOSITIONS FOR ORAL ADMINISTRATION OF PROTEINS
WO2007024743A3 (en) Proteolysis resistant antibody preparations
NZ594814A (en) Peptide that is derived from a milk protein and has an antioxidative effect and also acts as a blood adiponectin level increase promotion and/or decrease inhibition agent
NZ623123A (en) A process for concentration of a polypeptide
DK1546316T3 (da) Mutant E. Coli-AppA-fytaseenzymer og naturlige varianter deraf, nukleinsyrer, der koder for sådanne fytaseenzymer, vektorer og værtsceller, som inkorporerer disse og fremgangsmåder til at fremstille og anvende disse
TW200514790A (en) Bispecific antibody substituting for functional protein
TW200806317A (en) Methods for reducing protein aggregation
EP1350842A3 (de) Rekombinante terminale Deoxynukleotidyltransferase mit verbesserter Funktionalität
MY153198A (en) Inhibitors of protein aggregation
WO2007064917A3 (en) Methods of preparation of recombinant forms of human beta-amyloid protein and uses of these proteins
NZ598176A (en) Disintegrin variants and pharmaceutical uses thereof
SG163600A1 (en) Methods for the treatment of muscle loss
WO2005117977A8 (en) Tissue-specific imaging and therapeutic agents targeting proteins expressed on lung endothelial cell surface
NZ598056A (en) Blood coagulation protein conjugates
BRPI0411650A (pt) variante polipeptìdica do fator vii (fvii) ou do fator viia (fviia), sequencia de nucleotìdeos , vetor de expressão, célula hospedeira, composição, uso de uma variante, e, método para tratar de um mamìfero tendo uma doença ou um distúrbio em que a formação de coágulo seja desejável
NO20072661L (no) Rensing av glykopeptider
DE602007014210D1 (de) Prophylaktisches/therapeutisches mittel für neurodegenerative erkrankungen
WO2007061939A3 (en) Metabolite derivatives of the hdac inhibitor fk228
NZ601592A (en) Recombinant elastase proteins and methods of manufacturing and use thereof
WO2006114105A3 (en) Use of modified factor vii for treating bleeding
AU2003229284A1 (en) Active substances for the treatment, diagnosis and prophylaxis of diseases in which abnormal protein structures occur
WO2002055552A3 (de) Lösliche cyclische analoga des beta amyloiden peptides
WO2006100679A3 (en) Recombinant antibodies against human type ii transglutaminase and uses thereof